Inappropriate use of antimicrobial is not only a major cause of antimicrobial resistance but also a huge waste of expenditure in many countries including Thailand. The consensus of focus groups has suggested that intervention called drug use evaluation (DUE) might be used as a tool for solving this problem. However, it was noted that an explicit po

There is increasing impetus to use pharmaceutical interventions, ie, ranibizumab or bevacizumab, for the treatment of particular macular diseases. This study conducts the evidence synthesis to inform policy decision-making of the National List of Essential Medicines Committee that recently announced the inclusion of bevacizumab for the treatment of

This study aimed to evaluate cost-effectiveness of peritoneal dialysis (first policy) and freely chosen of dialysis modality. Decision analysis model was constructed for cost effectiveness analysis. Parameters in the model were obtained from the literature review and Thailand Renal Replacement Therapy (TRT) registry database analysis.  201-357-25

The CMCC aims to enhance the informed use of COVID-19 models in policy making, by providing end users (with focus on LMICs) with an accessible overview of the aims, capabilities and limits of the existing COVID-19 models, how projections differ and what the models’ key assumptions/drivers are. The CMCC is convened by BMGF, the Centers for Disease

This two part study will include a systematic review of economic evaluations of AMR interventions and a policy analysis to identify AMR policies currently implemented in LMICs. In combination, both these research studies will be able to address an important knowledge gap and recognise which countries currently implement evidence-informed AMR polici

Adapting a dynamic transmission model developed by National University of Singapore to the Philippines context, in order to address policy questions around COVID-19 vaccine choice, target population for booster doses, and the impact of social gatherings on COVID-19 spread.

This is an ongoing work built upon the previous work of HITAP in developing and improving the pay-for-performance scheme for primary care services through Quality and Outcome Framework (QOF). This phrase is particularly focusing on developing the dialogue of QOF use and its implementation with policy makers.Documents

โรคข้ออักเสบรูมาตอยด์ (rheumatoid arthritis หรือ RA) เป็นโรคข้ออักเสบชนิดไม่ทราบสาเหตุ (idiopathic inflammatory arthritis) ที่มีการอักเสบเรื้อรังของเยื่อหุ้มข้อ

63231002RM 023L0Chronic Hepatitis C,HCV,Hepatitis C Virus,sof/vel,sofosbuvir,velpatasvir,ไวรัสตับอักเสบซี

67194067MU033L0